Scarica l'app Stockscreener
132.04
0.69%
0.91
Dopo l'orario di chiusura:
132.98
0.94
+0.71%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$131.13
Aprire:
$132.09
Volume 24 ore:
994.80K
Relative Volume:
0.91
Capitalizzazione di mercato:
$4.50B
Reddito:
$401.09M
Utile/perdita netta:
$32.64M
Rapporto P/E:
140.47
EPS:
0.94
Flusso di cassa netto:
$-120.51M
1 W Prestazione:
+11.14%
1M Prestazione:
+17.41%
6M Prestazione:
+85.40%
1 anno Prestazione:
-18.49%
Intervallo 1D:
$127.70
$133.54
Intervallo di 1 settimana:
$114.30
$133.54
Portata 52W:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Confronta TMDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
132.04 | 4.34B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Acquired by Montanaro Asset Management Ltd - MarketBeat
What Technical Tools Say About TransMedics Group Inc. RecoveryOil Prices & Short-Term Trading Alerts - 선데이타임즈
Headlands Technologies LLC Sells 2,903 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
When is the best time to buy TransMedics Group Inc. stockFree Stock Portfolio Allocation Guidance - Newser
Can TransMedics Group Inc. hit a new high this monthYield Curve Outlook and Long-Term Implication Summary - Newser
How TransMedics Group Inc. stock performs during market volatility [Weekly Loss Report]Free AI Powered Market Trend Analysis - Newser
How to monitor TransMedics Group Inc. with trend dashboardsFree Daily Chart Pattern Stock Forecast - Newser
Live market analysis of TransMedics Group Inc.Pattern Breakout Tracker with Screener Tools - Newser
TransMedics Group (NASDAQ:TMDX) Shares Gap UpHere's What Happened - MarketBeat
Transmedics Group Inc (TMDX) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Q2 2025 slides: revenue surges 38%, company raises full-year guidance By Investing.com - Investing.com South Africa
TransMedics Q2 2025 slides: revenue surges 38%, company raises full-year guidance - Investing.com Nigeria
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Exit strategy if you’re trapped in TransMedics Group Inc.Investment Position Summary with Timeframe Forecast - Newser
TransMedics Group Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
Next-Gen Heart Trial and Raised Outlook Might Change the Case for Investing in TransMedics (TMDX) - Yahoo Finance
Order flow analysis tools used on TransMedics Group Inc.Trade Plan With Low Risk High Return - Newser
TransMedics Soars 11% on $270M Volume Surge Jumps Into Top 500 Stocks as Earnings Outlook and FDA Approval Drive Momentum - AInvest
Surge in TransMedics: Are Big Gains Ahead? - StocksToTrade
TransMedics Group’s Unexpected Growth: A Closer Look - timothysykes.com
Spotlight on TransMedics Group: Analyzing the Surge in Options ActivityTransMedics Group (NASDAQ:TMDX) - Benzinga
Hedge Fund and Insider Trading News: Carl Icahn, Ken Griffin, Warren Buffett, Bill Ackman, Schonfeld Strategic Advisors, TransMedics Group Inc (TMDX), Carvana Co (CVNA), and More - Insider Monkey
TransMedics rises after CEO buys company stock - MSN
TransMedics rises after CEO buys company stock (TMDX:NASDAQ) - Seeking Alpha
TransMedics Shares Surge on Positive FDA Approval for Heart Trial - StocksToTrade
Insider Buying Report: TransMedics Group CEO and Pinnacle Financial Partners Director Purchase Shares - AInvest
TransMedics Stock Climbs After FDA Approval Sparks Optimism - timothysykes.com
Published on: 2025-08-11 17:55:02 - beatles.ru
TransMedics Group Inc. stock momentum explainedVolume Confirmed Setup with Entry Confidence - Newser
Is TransMedics Group Inc. a candidate for recovery playConservative Equity Setup with Signal Analysis - Newser
Why TransMedics Group Inc. is moving todayFast Entry Strategy with Price Prediction - Newser
Institutional scanner results for TransMedics Group Inc.ROI Focused Setup With Drawdown Analysis - Newser
TransMedics Group Inc. stock trend forecastDaily Exit and Entry Price Prediction - Newser
Using data tools to time your TransMedics Group Inc. exitEntry Optimization Guide with Volume Analysis - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect - ACCESS Newswire
TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Call Transcript - MSN
Developing predictive dashboards with TransMedics Group Inc. dataFree Early Breakout Entry Point Notifications - Newser
Blair William & Co. IL Sells 105,569 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Will TransMedics Group Inc. outperform the marketValue Investing Summary and Earnings Outlook - Newser
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Can trapped investors hope for a rebound in TransMedics Group Inc.Trend Following Ideas with Volume Confirmation - Newser
TransMedics Group CEO Makes Significant Stock Purchase, Boosting Investor Confidence - AInvest
Why TransMedics Group Stocks Are Soaring - TipRanks
Applying Wyckoff theory to TransMedics Group Inc. stockFree Capital Efficiency Optimized Stock Alerts - Newser
CEO’s Bold Move: Major Stock Purchase Signals Confidence in TransMedics - TipRanks
TransMedics Sees Its Earnings Soar - AOL.com
TransMedics Group CEO Hassanein Waleed H buys 16835 shares at $118.68/share. - AInvest
TransMedics Group (NASDAQ:TMDX) Stock Price Up 6.8% on Analyst Upgrade - MarketBeat
Advanced analytics toolkit walkthrough for TransMedics Group Inc.Daily Market Entry Strategy with Tools - Newser
Allianz Asset Management GmbH Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hassanein Waleed H | President & CEO |
Aug 07 '25 |
Buy |
116.25 |
8,475 |
985,209 |
486,234 |
| Basile Edward M | Director |
Aug 04 '25 |
Option Exercise |
0.70 |
4,143 |
2,900 |
7,009 |
| Basile Edward M | Director |
Aug 04 '25 |
Sale |
125.51 |
4,143 |
519,988 |
2,866 |
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):